Contact Us

Vioxx
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

Phone 

Cell Phone 

Street Address 

Zip Code 

City 

State 

Date you started taking this drug:

Date you stopped taking this drug:

What condition was this medication prescribed to treat?

What dosage were you prescribed daily?

Have any of the following side effects occurred? (Please check all that apply.)





Please further describe side effects:

For verification purposes, please answer the below question:
+
=

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.


Ky. Man Files Class-Action Suit Over Vioxx

Oct 25, 2004 | AP

An eastern Kentucky man has filed a class action lawsuit against the maker of Vioxx, the recently recalled arthritis drug.

The plantiff's suit was filed against
Merck & Co. on Friday in Pike County Circuit Court.

The suit claims Merck deceived its customers by promoting Vioxx as being safe and said the company knew the drug had safety risks associated with its use.

Tracy Ogden, a spokeswoman for the company, had no immediate comment on the suit.

New Jersey-based Merck announced Sept. 30 that it was pulling the medication from shelves over fears users faced increased risk of heart attack and stroke.

The lawsuit was filed as a class action although Radcliff is the only named plaintiff. He is asking for damages of up to $75,000 and the creation of a fund to pay for future economic losses and medical care.

Ratliff claims in his suit that the company knew about the drug's risks since "shortly after the drug was approved for use" by the federal Food and Drug Administration in May 1999. He said that despite growing evidence of the drug's problems, Merck continued to market the drug.

Merck is one of the world's largest drug makers, and Vioxx was its popular medication for arthritis as well as acute pain and disorders such as carpal tunnel syndrome. The drug accounted for $2.5 billion in worldwide sales last year.

Some 84 million prescriptions have been filled since the drug's introduction.

The Lexington law firm filed a federal suit on behalf of two Bourbon County residents earlier this month. Similar lawsuits are in the works across the country.


Related articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo